EUVIMEDEUVIMED entdecken
Crossref

Traditional Chinese medicine formulation Chang-Kang-Fang restores gut-brain homeostasis in IBS-D via the Lactobacillus johnsonii-indole-3-lactic acid-aryl hydrocarbon receptor/interleukin-22 axis

Fengge Yang, Danmei Tian, Yuting Zhang, Zixuan Xia, Yunjuan Li, Xinsheng Yao, Yanxia Xiong, Guirong Zhou, Hongwei Liu, Jinshan Tang

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Fengge Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Asse…. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Drugs, Chinese Herbal. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gut dysbiosis contributes to irritable bowel syndrome (IBS) by disrupting intestinal barrier functions and promoting inflammation. Chang‑kang‑fang (CKF), a Chinese herbal formula proven effective for diarrhea‑predominant IBS (IBS‑D) in a phase III trial, is thought to modulate the gut microbiota, yet the underlying mechanism remains unclear. PURPOSE: To elucidate how CKF ameliorates IBS‑D by modulating the gut microbiota. METHODS: IBS‑D was induced by restraint stress, tail pinch, and senna gavage. Intestinal function, inflammation, and behavior were evaluated. Gut microbiota and metabolites were profiled via 16S rRNA sequencing and metabolomics. FMT confirmed the causal involvement of the microbiota. The key microbe and metabolite were validated in vivo. Mechanistic analyses evaluated intestinal barrier integrity, systemic inflammation, hippocampal blood‑brain barrier (BBB) function, neuroinflammation, and synaptic plasticity. RESULTS: CKF alleviated diarrhea, visceral hypersensitivity, inflammation, barrier dysfunction, and anxiety‑ and depression‑like behaviors. These benefits were associated with gut microbiota remodeling, featuring enrichment of Lactobacillus johnsonii and enhanced tryptophan metabolism. FMT confirmed that this microbial remodeling mediates the therapeutic effects of CKF. Supplementation with L. johnsonii or its metabolite indole‑3‑lactic acid (ILA) largely recapitulated these gut-brain benefits via AhR/IL‑22 activation. Mechanistically, CKF‑induced L. johnsonii enrichment activated the ILA-AhR-IL‑22 pathway, which enhanced intestinal and BBB integrity, thereby attenuating systemic and neuroinflammation, and restoring hippocampal synaptic plasticity. CONCLUSION: This study positions CKF as a microbiota‑modulating therapy for IBS‑D that restores gut‑brain homeostasis via the L. johnsonii-ILA-AhR-IL‑22 axis, highlighting L. johnsonii and ILA as potential therapeutics for IBS and its comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeDrugs, Chinese HerbalAnimalsGastrointestinal MicrobiomeHomeostasisInterleukinsInterleukin-22Receptors, Aryl HydrocarbonMaleIntestinal Barrier FunctionLactobacillusBrainBlood-Brain BarrierMiceIndolesBrain-Gut AxisRats, Sprague-Dawley

Stichwörter der Autor:innen

Chang-kang-fangGut microbiotaIBS-DL. johnsonii-ILA-AhR/IL-22 gut-brain axisTryptophan metabolism

Substanzen

Drugs, Chinese HerbalInterleukinsInterleukin-22Receptors, Aryl HydrocarbonIndoles

Autor:innen und Institutionen

  • Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Med…
  • State Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China; Savaid Medical School, University of Chinese Academy of Sciences, B…
  • State Key Laboratory of Chinese Medicine Modernization, Tasly Pharmaceutical Group Co., Ltd., Tianjin, 300410, China; Tianjin Key Laboratory of Component-Based Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tia…
  • China Resources Jiangzhong Pharmaceutical Co., Ltd., Nanchang, 330096, China; State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Nanchang, 330096, China.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Yang, F., Tian, D., Zhang, Y., Xia, Z., Li, Y., Yao, X., Xiong, Y., Zhou, G., Liu, H., & Tang, J. (2026). Traditional Chinese medicine formulation Chang-Kang-Fang restores gut-brain homeostasis in IBS-D via the Lactobacillus johnsonii-indole-3-lactic acid-aryl hydrocarbon receptor/interleukin-22 axis. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158786

Vancouver

Yang F, Tian D, Zhang Y, Xia Z, Li Y, Yao X, et al. Traditional Chinese medicine formulation Chang-Kang-Fang restores gut-brain homeostasis in IBS-D via the Lactobacillus johnsonii-indole-3-lactic acid-aryl hydrocarbon receptor/interleukin-22 axis. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158786

BibTeX
@article{Yang2026,
  author = {Yang, Fengge and Tian, Danmei and Zhang, Yuting and Xia, Zixuan and Li, Yunjuan and Yao, Xinsheng and Xiong, Yanxia and Zhou, Guirong and Liu, Hongwei and Tang, Jinshan},
  title = {Traditional Chinese medicine formulation Chang-Kang-Fang restores gut-brain homeostasis in IBS-D via the Lactobacillus johnsonii-indole-3-lactic acid-aryl hydrocarbon receptor/interleukin-22 axis},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158786}
}
Kostenlos starten →